Preprint
Article

This version is not peer-reviewed.

Evaluation of the Relationship Between Clinical Frailty Scale (CFS) and Mortality in Geriatric Patients with Pneumonia-Diagnosed in Intensive Care

A peer-reviewed article of this preprint also exists.

Submitted:

19 March 2025

Posted:

20 March 2025

You are already at the latest version

Abstract
Background and Aim: Frailty can represent the transitional stage between successful aging and old age in need of care; it is a guide for setting goals for regaining robust old age in the individual at risk. Frailty is associated with longer intensive care unit duration, hospital stay, and higher mortality.The aim of this study was to evaluate the relationship between mortality and frailty in geriatric patients (65 years and older) admitted to the intensive care unit with a diagnosis of pneumonia. Methods: 478 patients were included in the study. The demographic data such as age, gender, body mass index(BMI), Charlson Comorbidite Index(CCI), Clinical Frailty Scale (CFS), Acute Physiology and Chronic Health Evaluation (APACHE II) scores, Sequential Organ Failure Assessment Score (SOFA), invasive/noninvasive mechanical ventilator days, length of stay hospital and intensive care unit, inotropic requirement, and 28-day mortality were retrospectively scanned and recorded. Results: Advanced age, lower BMI, higher Charlson Comorbidity Index (CCI), SOFA score, and CFS increase 28-day mortality. CFS was found to be associated with 28-day mortality similar to the use of inotropic agents, prolonged MV duration, and ICU length of stay (LOS). Conclusion: CFS is effective in predicting 28-day mortality in geriatric patients diagnosed with pneumonia in intensive care. It also provides insights into morbidity parameters such as, requirement for inotropic agents, duration of mechanical ventilation (MV), and LOS ICU.
Keywords: 
;  ;  ;  ;  ;  

1. Introduction

Aging and old age are complex phenomena. Biologically, aging is associated with molecular and cellular damage that leads to a decrease in physiological capacity and an increased risk of various diseases. This decline in capacity is not linearly related to age. While some individuals over 65 lead physically and mentally active lives, others may require significant medical support to meet their basic life needs [1]. The elderly population (aged 65 and older] worldwide is expected to increase by 25% from 2021 to 2050, effectively doubling the elderly population [2]. A ratio of the elderly population exceeding 10% of the total population is considered an indicator of population aging [3]. With this anticipated significant increase, the early identification of risk factors and the timely addressing of clinical needs have become increasingly important in health management [4]. As the number of individuals reaching advanced ages grows, the need to subdivide the aging population into specific subgroups has arisen. For this purpose, the World Health Organization (WHO) has categorized the population aged 65 and over into three subgroups: “young elderly” (65-74 years), “middle elderly” (75-84 years), and “old elderly” (85 years and older) [5].
Frailty is defined as a reduced ability of physiological systems to cope with acute stressors due to clinically recognizable aging [6]. Frailty can represent a transitional stage between successful aging and dependence on care in old age; it serves as a guide for establishing goals for achieving robust old age in individuals at risk [4]. Frail elderly individuals are less resilient to illness and are more prone to hospitalization compared to younger individuals and non-frail older adults. In this regard, frailty is associated with an increased risk of complications from medical procedures and early mortality [5].
The increase in frailty among the elderly population also leads to a worsened response to comorbidities. Consequently, rising frailty is associated with longer durations in intensive care units, longer hospital stays, and higher mortality rates [7,8]. Identifying frailty as a target for preventive interventions for age-related diseases is essential. Frailty accounts for approximately 30% of admissions to intensive care units [5].
Frailty is not solely associated with aging but is also prevalent among patients admitted to intensive care due to critical illnesses [9]. While the severity of illness increases the risk of acute death, recent data suggest that long-term outcomes are more closely related to the patient’s prior health status [10]. Frail patients who experience critical illness face a higher risk of death [9].
The progressive age-related decline in physiological systems, combined with chronic diseases and conditions, ultimately leads to decreased functional reserve capacity. Increased vulnerability heightens the risk of adverse health events, including hospital or intensive care unit admissions and death [11,12]. The state of frailty may exhibit characteristics of reversibility, especially in its earliest stages. Lee et al. reported that frailty can vary based on negative factors (such as older age, cancer history, hospitalization events, chronic obstructive pulmonary disease, cerebrovascular disease, and osteoarthritis) and positive factors (such as higher cognitive function, absence of diabetes, higher socioeconomic status, and lack of cerebrovascular disease history) associated with the patient’s condition [13].
The aim of this study is to evaluate the relationship between frailty and mortality in geriatric patients (aged 65 and older) admitted to the intensive care unit with a diagnosis of pneumonia. Patients included in the study were classified into “young elderly” (65-74 years), “middle elderly” (75-84 years), and “old elderly” (85 years and older), and their frailty indices were categorized as non-frail (CFS 1-4), mildly/moderately frail (CFS 5-6), and severely/very severely frail (CFS 7-8).

2. Material and Methods

After obtaining the approval of the Ethics Committee of Ankara Ataturk Sanatorium Training and Research Hospital dated 30.03.2023 and numbered E-53610172-799-212114999, patients who were admitted to the 3rd level Anesthesiology & Reanimation and Chest Diseases Intensive Care Units(ICU) between 1 April 2018 and 31 December 2022 were scanned and 500 patients aged 65 years and over with a diagnosis of pneumonia were included in the study. 22 of them were excluded from the study due to missing data. 478 patients were included in the study.
The demographic data such as age, gender, body mass index(BMI), Charlson Comorbidite Index(CCI), Clinical Frailty Scale (CFS), Acute Physiology and Chronic Health Evaluation (APACHE II) scores, Sequential Organ Failure Assessment Score (SOFA), invasive/noninvasive mechanical ventilator days, length of stay hospital and intensive care unit, inotropic requirement, and 28-day mortality were retrospectively scanned and recorded. CFS, APACHE II, and SOFA scores were assessed and recorded within the first 24 h of intensive care unit admission. Information regarding 28-day mortality was obtained from the death notification system.
Exclusion criteria:
  • ✓ Patients hospitalized for palliative care, without a diagnosis of pneumonia
  • ✓ Under 65 years of age,
  • ✓ Patients with missing data
  • ✓ In the event of multiple ICU admissions during a hospital stay, only the first was included in the study.

3. Statistical Analysis

Data analyses were performed by using SPSS for Windows, version 22.0 (SPSS Inc., Chicago, IL, United States). Whether the distribution of continuous variables was normal or not was determined by the Kolmogorov Smirnov test. Levene test was used for the evaluation of homogeneity of variances.
Categorical data were described as a number of cases (%). Statistical analysis differences in not normally distributed variables between two independent groups were compared by Mann Whitney U test. Statistical analysis differences in not normally distributed variables between three independent groups were compared by Kruskal wallis test. Categorical variables were compared using Pearson’s chi-square test or fisher’s exact test. It was evaluated degrees of relation between variables with spearman correlation analysis.
Univariate and multivariate logistic regression analyses were performed to assess the association between mortality, and the risk factors findings.
Univariate and multivariate linear regression analyses were performed to assess the association between NIMV days, MV days, LOS ICU and LOS H and the risk factors findings.
First of all it was used one variable univariate logistic/linear regression with risk factors that is thought to be related with 28-day mortality. Risk factors that has p-value < 0.25 univariate variable logistic/linear regression was included to model on multivariable logistic/linear regression. Enter model used in multivariable logistic/linear regression. Whether every independent variables were significant on model was analyzed with Wald statistic on multivariable logistic regression. Whether every independent variables were significant on model was analyzed with t statistic on multivariable linear regression.
It was accepted p-value <0.05 as significant level on all statistical analysis.
Table 1. Clinical Frailty Scale (CFS) [14].
Table 1. Clinical Frailty Scale (CFS) [14].
1. Very Fit: People who are vigorous, active and full of energy. They often exercise regularly. They are the most vigorous among their peers. 6. Moderately Frail: Completely dependent on all outside-the-home activities and household chores.
2.Good: No symptoms of active disease, but less vigorous than people in category 1. They exercise frequently or are occasionally very active. For example: Seasonal 7. Severely Frail: Completely dependent on someone else for personal care for any reason (physical or cognitive). However, people who appear stable and are not at high risk of death (within about 6 months).
3.Can Manage Well: These are people whose medical problems are under control and who are not active other than regular walking. 8. Very Severely Frail: People who are completely dependent and are nearing the end of their lives. People who typically cannot recover from even a mild illness.
4. Vulnerable: Although he is not dependent on others in his daily work, his movements are limited due to disease symptoms. Their general complaints are slowness and/or feeling tired throughout the day. 9. Terminal Disease: People who are nearing the end of their lives. This category should be applied to those with a life expectancy of less than 6 months, even without being frail.
5. Slightly Frail: More significant slowing down of movements, needing assistance in highly instrumental daily living activities (financial issues, transfer/travel, heavy housework, medication use). Typically, mild frailty progressively impairs ability to shop, walk outside alone, prepare meals, and do household chores.

4. Results

Demographic data are shown in Table 2. The largest patient group was the young elderly group with 190 patients and 63.8% of the patients participating in the study were in the Severe Frail CFS group.
There is a negative, low statistically significant relationship between NIMV duration and CFS, CCI, APACHE II, SOFA. There is a positive, moderately statistically significant relationship between MV Duration and CFS, APACHE II and SOFA. There is a positive, low statistically significant relationship between MV duration and CCI (Table 3).
There is a positive, low statistically significant relationship between LOS ICU and CFS. There is a negative, low statistically significant relationship between LOS hospital and CCI. There is a negative and low statistically significant relationship between the LOS hospital and SOFA (Table 3).
Age, CFS, CCI, APACHE II, SOFA and MV days were statistically significantly higher in those who received inotropic support compared to those who did not.
BMI, NIMV days and LOS H were found to be statistically significantly lower in those who received inotropic support compared to those who did not. We believe that the duration of NIMV was less because the patient whose clinical condition deteriorated went to intubation. The short hospitalization period may also be related to the mortal course of this patient group (Table 4).
MV duration and LOS ICU were found to be statistically significantly higher as CFS increased. Similarly, inotropic requirement and the 28-day mortality rate were found to be significantly higher as CFS increased (Table 5).
Logistic regression analysis was applied to determine the factors that increase the risk of 28-day mortality over the patients included in the study.
Firstly, univariate logistic regression analysis was applied for the factors thought to be associated with 28-day mortality. In univariate logistic regression analysis, increase in age (odds ratio=1.032, p=0.008), decrease in BMI (odds ratio=0.954, p=0.004), increase in CCI (odds ratio=1.612 , p=<0.001), increase in APACHE II (odds ratio=1, 167 , p=<0.001), increased SOFA (odds ratio=2.849, p=<0.001), increased CFS (odds ratio=3.520, p=<0.001) were considered to be factors that increased the risk of 28-day mortality.
Variables with p<0.25 in the univariate analysis were included in the multivariate analysis.
While 28-day mortality was included in the multivariate logistic regression analysis in order to create the model that would best explain the risk of 28-day mortality, variables with no significant relationship were excluded from the analysis. The model found in the multivariate linear regression analysis is statistically significant. According to the results of multivariate logistic regression analysis, increase in age (odds ratio=1.021, p=0.024), decrease in BMI (odds ratio=0.947, p=0.023), increase in CCI (odds ratio=1.256, p=0.013), increased SOFA (odds ratio=2.452, p=<0.001), increased CFS (odds ratio=2.533, p=<0.001) were found to increase the risk of 28-day mortality (Table 6).

5. Discussion

This study has shown that older age, lower BMI, higher CCI, SOFA and CFS increase 28-day mortality. CFS was found to be associated with 28-day mortality just like (+) inotrope use, increase in MV duration, LOS ICU. A negative correlation was found between NIMV days and CFS. We believe that the duration of NIMV was less because the patient whose clinical condition deteriorated went to intubation. The short hospitalization period may also be related to the mortal course of this patient group.
Frailty is important for understanding critical illnesses. Knowing frailty status is important in intensive care triage and management of the patient’s treatment. Assessment of frailty during ICU admission has become increasingly popular. The clinical frailty scale (CFS) has proven to be a reliable tool for predicting ICU survival in intensive care patients [7,15,16].
In a study, CFS was identified as a prognostic factor in patients aged 65 and older, demonstrating an independent association with outcomes following adjustment for relevant co-factors [17]. However, they found inconsistent associations between CFS and ICU mortality in younger patients. This diference may be sensible, because younger patients, even if they are frail, might still survive in ICU admission. They suggested that CFS scores of 5 and higher are notably effective, whereas scores of 4 and lower may influence long-term outcomes [17]. Since approximately 92% of our patients in our study had CFS 5 and above, we did not make a comparison between groups, but we found that the increase in CFS was directly proportional with mortality. A study on covid-19, examined the use of the Clinical Frailty Scale (CFS) for ICU triage in COVID-19 pneumonia, finding that CFS scores of 5 and above were good prognostic indicators for ICU admission. However, they noted that it did not support ICU admission for non-frail and mildly frail groups [18].
The World Health Organization defines frailty as the clinical condition in which older people’s ability to cope with both routine and acute stressors is diminished. Older age is often associated with, but not synonymous with, frailty [19]. In our study, while age was not found to be related to the criteria that we accept as the patient’s morbidity (MV duration, NIMV duration, LOS ICU or LOS H), CFS was found to be proportionally related to MV duration and LOS ICU.
Additionally, the CFS score was found to be associated with 1-year mortality, regardless of age and disease. It was stated that even if the CFS score of the patients was low during their admission to the intensive care unit, they may be discharged with a higher CFS and this could also affect mortality [20].
Likewise, a study reported associations between frailty and mortality, palliative care admissions, and the need for mechanical ventilation. It was stated that the presence of frailty along with a qSOFA score greater than 2 increases the risk of mortality [8]. Similarly, in our study, we found an association between increasing CFS score and duration of mechanical ventilation (MV), requirement for inotropes, LOS ICU, and 28-day mortality. Additionally, CFS affects morbidity parameters (such as the need for inotropic support and MV duration) alongside intensive care severity scores like APACHE II and SOFA. Furthermore, one study emphasized that CFS should be used as a screening tool for frailty in critically ill patients of all ages, not only in geriatric patients, due to its effective predictive ability [21].
Our study has some limitations. Firstly, the study population is small. Secondly, it is single-center. Thirdly, there is a predominance of patients with high CFS scores. Fourthly, there are challenges in assessing frailty; however, it is necessary to rely on proxies (such as family members) for scoring. Lastly, younger patients were not included for comparison.
Consequently, CFS is effective in predicting 28-day mortality in geriatric patients diagnosed with pneumonia in intensive care. It also provides insights into morbidity parameters such as, requirement for inotropic agents, duration of mechanical ventilation (MV), and LOS ICU.Due to limited resources in intensive care, frailty assessment of older patients could be included in comprehensive patient assessment.

Author Contributions

All of the authors declare that they have all participated in the concept, design, literature search, data collection, analyses, writing and that they have approved the final version.

Funding sources

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Compliance with Ethical Standards

All the authors mentioned in the manuscript have agreed for authorship, read and approved the manuscript, and given consent for submission and subsequent publication of the manuscript. The manuscript in part or in full has not been submitted or published anywhere.

Ethics Committee Approval

Ethical Decision No: E-53610172-799-212114999 dated 30.03.2023, Ankara Ataturk Sanatorium Training and Research Hospital, Clinical Research Ethics Committee.

Data Access Statement

All relevant data are within the paper and its Supporting Information files.

Acknowledgments

None.

Conflicts of Interest

The authors have declared that no competing interests exist.

References

  1. World Health Organization. “WHO clinical consortium on healthy ageing 2022: report of consortium meeting, 5–6 December 2022.” ; 2023.
  2. He W, Goodkind D, Kowal PR. An aging world: 2015. Washington, DC: United States Census Bureau; 2016.
  3. United Nations Department of Economic and Social Affairs. World Social Report 2023: Leaving No One Behind in an Ageing World. UN.; 2023.
  4. Cesari M, Prince M, Thiyagarajan JA, De Carvalho IA, Bernabei R, Chan P, et al. Frailty: An Emerging Public Health Priority. J Am Med Dir Assoc. 2016, 17, 188–92. [Google Scholar] [CrossRef] [PubMed]
  5. Bilir, N. Yaşlılık Tanımı, Yaşlılık Kavramı, Epidemiyolojik Özellikler, Yaşlılık ve Solunum Hastalıkları, ed. A. Ertürk, A. Bahadır, F. Koşar, TÜSAD, Türkiye Solunum Araştırmaları Derneği; 2018.
  6. Pel-Littel RE, Schuurmans MJ, Emmelot-Vonk MH, Verhaar HJJ. Frailty: defining and measuring a concept. J Nutr Heal Aging. 2009;13:390-4.
  7. Muscedere J, Waters B, Varambally A, Bagshaw SM, Boyd JG, Maslove D, et al. The impact of frailty on intensive care unit outcomes: a systematic review and meta-analysis. Intensive care medicine. 2017;43:1105-22.
  8. Fernando SM, McIsaac DI, Perry JJ, Rochwerg B, Bagshaw SM, Thavorn K, et al. Frailty and associated outcomes and resource utilization among older ICU patients with suspected infection. Critical Care Medicine 2019, 47, e669-76. [Google Scholar]
  9. Montgomery CL, Rolfson DB, Bagshaw SM. Frailty and the association between long-term recovery after intensive care unit admission. Critical care clinics. 2018, 34, 527–47. [Google Scholar] [CrossRef] [PubMed]
  10. Haas B, Wunsch H. How does prior health status (age, comorbidities and frailty) determine critical illness and outcome? Current opinion in critical care 2016, 22, 500–5. [Google Scholar] [CrossRef] [PubMed]
  11. Fried LP, Walston JD, Ferrucci L. Frailty In: Halter JB, Ouslander JG, Tinetti ME, et al., editors. Hazzard’s Geriatric Medicine and Gerontology. New York, NY: McGraw-Hill Medical; 2009. p. 631e645.
  12. Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. The lancet. 2013;381(9868):752-62.
  13. Lee JS, Auyeung TW, Leung J, Kwok T, Woo J. Transitions in frailty states among community-living older adults and their associated factors. Journal of the American Medical Directors Association. 2014;15(4):281-6.
  14. Hartley P, Adamson J, Cunningham C, Embleton G, Romero-Ortuno R. Clinical frailty and functional trajectories in hospitalized older adults: a retrospective observational study. Geriatrics & gerontology international. 2017;17(7):1063-8.
  15. Flaatten H, De Lange DW, Morandi A, Andersen FH, Artigas A, Bertolini G, et al. The impact of frailty on ICU and 30-day mortality and the level of care in very elderly patients (>/= 80 years). Intensive Care Med. 2017;43(12):1820–8.
  16. Flaatten H, Guidet B, Andersen FH, Artigas A, Cecconi M, Boumendil A, et al. Reliability of the Clinical Frailty Scale in very elderly ICU patients: a prospective European study. Ann Intensive Care. 2021;11(1):22.
  17. Bruno RR, Wernly B, Bagshaw SM, van den Boogaard M, Darvall JN, De Geer L, et al. The Clinical Frailty Scale for mortality prediction of old acutely admitted intensive care patients: a meta-analysis of individual patient-level data. Annals of Intensive Care. 2023;13(1):37.
  18. Darvall JN, Bellomo R, Bailey M, Paul E, Young PJ, Rockwood K, et al. Frailty and outcomes from pneumonia in critical illness: a population-based cohort study. British Journal of Anaesthesia. 2020;125(5):730-8.
  19. Jung C, Bruno RR, Wernly B, Wolf G, Beil M, Kelm M. Frailty as a prognostic indicator inintensive care. Dtsch Arztebl Int. 2020;117(40):668–73.
  20. Remelli F, Scaramuzzo G, Capuzzo M, Maietti E, Berselli A, Denti M, et al. Frailty trajectories in ICU survivors: A comparison between the clinical frailty scale and the Tilburg frailty Indicator and association with 1 year mortality. J Crit Care. 2023;78:154398.
  21. Brummel NE, Bell SP, Girard TD, Pandharipande PP, Jackson JC, Morandi A, et al. Frailty and subsequent disability and mortality among patients with critical illness. American journal of respiratory and critical care medicine. 2017;196(1):64-72.
Table 2. Demographic and other data of patients.
Table 2. Demographic and other data of patients.
n %
Age group Young elderly
(65-74)
190 39,7%
Middle-aged
(75-84)
175 36,6%
Elderly
(85 and over)
113 23,6%
Gender Female 205 43,0%
Male 272 57,0%
CFS group 1-4 31 7,8%
5-6 113 28,4%
7-8 254 63,8%
Inotropic requirement No 347 72,6%
Yes 131 27,4%
28-day mortality No 257 53,8%
Yes 221 46,2%
CFS: Clinical Frailty Scale.
Table 3. Correlation between risk factors and morbidity parameters of patients.
Table 3. Correlation between risk factors and morbidity parameters of patients.
NIMV Days MV Days LOS ICU LOS H
Age r -0,036 -0,032 0,008 -0,001
p 0,431 0,486 0,865 0,985
BMI r 0,053 -0,063 0,020 -0,042
p 0,245 0,166 0,665 0,364
CFS r -0,218 0,577 0,173 -0,082
p <0,001 <0,001 <0,001 0,075
CCI r -0,138 0,128 -0,041 -0,090
p 0,002 0,005 0,373 0,049
APACHE II r -0,177 0,349 0,056 -0,046
p <0,001 <0,001 0,225 0,319
SOFA r -0,292 0,499 0,055 -0,132
p <0,001 <0,001 0,229 0,004
r: correlation coefficient, spearman correlation. NIMV:Non Invasive Mechanic Ventilation, MV: Mechanic Ventilation, LOS ICU: Lenght of stay Intensive Care Unit. LOS H: Lenght of stay hospital, BMI: Body Mass Index, CFS: Clinical Frailty Scale, CCI:Charlson Comorbidite Index, APACHE II: Acute Physiology and Chronic Health Evaluation, SOFA:Sequential Organ Failure Assessment Score.
Table 4. The variables according to 28-day mortality status.
Table 4. The variables according to 28-day mortality status.
28-Day Mortality p
NO YES
Med (Q1-Q3) Med (Q1-Q3)
Age 77,0(70,0-82,0) 79,0(72,0-85,0) 0,005
BMI 26,0(22,2-29,3) 24,1(21,6-27,3) 0,002
CFS 7,0(6,0-7,0) 8,0(7,0-9,0) <0,001
CCI 6,0(5,0-7,0) 7,0(6,0-10,0) <0,001
APACHE II 20,0(17,0-24,0) 27,0(21,0-33,0) <0,001
SOFA 5,0 (5,0-6,0) 8,0(6,0-10,0) <0,001
NIMV duration 1, (0-3,0) 0 (0-1,0) <0,001
MV duration 0(0-0) 2,0(1,0-5,0) <0,001
LOS ICU 3,0(2,0-6,0) 4,0(2,0-8,0) 0,111
LOS H 16,0(10,0-24,0) 11,0(5,0-22,0) <0,001
Continuous variables are expressed as median (Q1-Q3),Mann Whitney u Test p=Level of Significance, p<0,05. BMI: Body Mass Index, CFS: Clinical Frailty Scale, CCI:Charlson Comorbidite Index, APACHE II: Acute Physiology and Chronic Health Evaluation, SOFA:Sequential Organ Failure Assessment Score, NIMV:Non Invasive Mechanical Ventilation, MV: Mechanical Ventilation, LOS ICU: Lenght of stay Intensive Care Unit, LOS H:Lenght of stay Hospital.
Table 5. The variables according to CFS groups.
Table 5. The variables according to CFS groups.
CFS p
1-4 5-6 7-8
Med (Q1-Q3) Med (Q1-Q3) Med (Q1-Q3)
NIMV duration 1,3 (0-3) 1,8(0-3) 1,8(0-2) 0,314Φ
MV duration 0(0-0) 0,7(0-0) 3,8(0-3) <0,001Φ
LOS ICU 3(2-4) 4,1(2-5) 6,9(2-8) 0,019Φ
LOS H 15,3(7-21) 17,8(10-23) 18,2(8-24) 0,123Φ
Inotropic requirement, n(%) - 9(8,0%) 68(26,8%) <0,001β
28-day Mortality, n(%) * 20(17,7%) 122(48,0%) <0,001β
Continuous variables are expressed as median (Q1-Q3) and categorical variables are expressed as either frequency (percentage).Mann Whitney u Test Φ, Chi square Test β p=Level of Significance, p<0,05. CFS:Clinical Frailty Scale, NIMV:Non Invasive Mechanical Ventilation, MV: Mechanical Ventilation, LOS ICU: Lenght of stay Intensive Care Unit, LOS H:Lenght of stay Hospital.
Table 6. Logistic Regression Analysis to Determine the Factors Affecting 28-Day Mortality.
Table 6. Logistic Regression Analysis to Determine the Factors Affecting 28-Day Mortality.
Univariate Logistic Regression Multivariate Logistic Regression
Wald p OR 95% C.I.for OR Wald p OR) 95% C.I.for OR
Lower Upper Lower Upper
Age 7,093 0,008 1,032 1,008 1,056 5,088 0,024 1,021 1,009 1,050
Gender 1,229 0,268 1,229 0,854 1,769
BMI 8,167 0,004 0,954 0,924 0,985 5,183 0,023 0,947 0,904 0,993
CCI 63,302 <0,001 1,612 1,433 1,813 6,227 0,013 1,256 1,050 1,502
APACHE II 77,005 <0,001 1,167 1,127 1,208 2,012 0,156 0,960 0,907 1,016
SOFA 103,183 <0,001 2,849 2,328 3,486 47,175 <0,001 2,452 1,898 3,166
CFS 107,597 <0,001 3,520 2,775 4,464 42,971 <0,001 2,533 1,919 3,345
Wald: test statistics, OR: odds radio, CI: Confidence interval. hosmer-lemeshow: p>0,05. p=Level of Significance, p<0,05. Statistically significant p-values are in bold. BMI: Body Mass Index, CCI:Charlson Comorbidite Index, APACHE II: Acute Physiology and Chronic Health Evaluation, SOFA:Sequential Organ Failure Assessment Score, CFS: Clinical Frailty Scale.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

Subscribe

Disclaimer

Terms of Use

Privacy Policy

Privacy Settings

© 2025 MDPI (Basel, Switzerland) unless otherwise stated